Original price was: $119.00.$70.00Current price is: $70.00.
Advanced regenerative peptide blend for cellular repair research.
Composition: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
CAS Number: 89030-95-5 (GHK-Cu) / 137525-51-0 (BPC-157) / 885340-08-9 (TB-500)
Form: Lyophilized Powder Blend
Quantity: 70mg total
Purity: ≥99% (HPLC verified)
Molecular Formula: C₁₄H₂₁CuN₆O₄ (GHK-Cu) / C₆₂H₉₈N₁₆O₂₂ (BPC-157) / C₃₈H₆₈N₁₀O₁₄ (TB-500)
Molecular Weight: 400.9 (GHK-Cu) / 1,419.5 (BPC-157) / 889.0 (TB-500) g/mol
Storage: −20°C recommended
Stability: 24+ months lyophilized
Category: Recovery & Regenerative Research
Use: Not for human or animal use. Research laboratory use only.
All major credit cards accepted
GLOW is a research-use-only blend supplied as a single laboratory preparation that combines three independently characterized peptides: GHK-Cu (copper tripeptide-1), BPC-157 (a stable pentadecapeptide sequence), and TB-500 (a synthetic fragment corresponding to a bioactive region of thymosin beta-4). Each constituent is a distinct compound with its own body of preclinical literature. GHK-Cu has been investigated for its role in copper coordination and extracellular matrix remodeling; BPC-157 has been examined in gastrointestinal and connective-tissue models; and the thymosin beta-4 fragment is studied in research on actin regulation and tissue-repair pathways. This material is intended solely for in vitro and laboratory investigation. Not for human or animal use. Research laboratory use only.
All compounds referenced are supplied for laboratory and research applications only and are not for human consumption.
GHK-Cu (glycyl-L-histidyl-L-lysine coordinated to copper(II)) is a naturally occurring tripeptide-copper complex. Research has examined its capacity to bind copper ions and its association with genes involved in extracellular matrix organization, including modulation of collagen and metalloproteinase expression in fibroblast models.1 Additional work has investigated its role in matrix remodeling and its interaction with signaling pathways relevant to connective-tissue biology.2
BPC-157, a stable pentadecapeptide derived from a sequence identified in gastric juice, has been investigated for its role in angiogenic and cytoprotective pathways within preclinical gastrointestinal and musculoskeletal systems. Reported research has examined its relationship to nitric oxide signaling, growth-factor receptor expression, and vascular network formation in experimental models.3
TB-500 corresponds to a synthetic fragment of thymosin beta-4, an actin-sequestering peptide. Research has examined thymosin beta-4 for its role in actin dynamics, cell migration, and tissue-repair pathways across a range of animal models, including its association with cellular motility and matrix interactions.4
The three constituents are described here individually; no combined or synergistic activity is implied. Each is characterized separately in the referenced literature and is provided for laboratory investigation only.
Not for human or animal use. Research laboratory use only.
KLOW
A professional platform for accessing research compounds with clarity, consistency, and research-first standards.
From sourcing to fulfillment, every step of our process is structured around clarity, consistency, and professional research standards.
Our platform is built to support efficient research workflows with organized categories, standardized product presentation, and simple reordering.
Every product is presented in formats designed for stability, professional handling, and alignment with laboratory environments.
4.8 Stars
Our approach prioritizes clarity, structure, and transparency. Each compound is presented with research-focused documentation, neutral communication, and consistent labeling to support scientific workflows.
We believe long-term trust is built through precision, not promotion.
